Clinical Test Expectation – Testagen – 20MG – Human Subjects : Normalizing / improving testosterone production as well as improve thyroid function / thyroid hormone production. Testosterone booster. Immunity booster. Anti-aging
Strength – 20MG per vial
Introduction
Testagen is a short, bioregulatory peptide that has primary effects on the pituitary gland and ultimately the thyroid gland. As a result of its action on these two glands, Testagen is capable of normalizing testosterone production as well as thyroid hormone production in certain settings.
Testagen is a short, bioregulatory peptide that has primary effects on the pituitary gland and ultimately the thyroid gland. As a result of its action on these two glands, Testagen is capable of normalizing testosterone production as well as thyroid hormone production in certain settings. By normalizing thyroid hormone production, Testagen has a moderate impact on the immune system. In these cases, Testagen can be conveniently thought of as resetting the pituitary gland to a more youthful state and thereby acting as an anti-aging peptide. Testagen is being researched for its ability to boost testosterone levels, improve thyroid hormone function, and stimulate the differentiation of stem cells in the immune system to improve immune function.
Dosing Details
You inject 2ml water into the vial of Testagen from the water vial. 1 full syringe is 1ml. You then wait for the vial powder content to dissolve ON ITS OWN. DO NOT SHAKE THE VIAL TO MIX POWDER. Once dissolved and clear in colour you draw out of the vial as follows :
Starting : 20 (0.2) on the syringe and inject it into the tummy under the skin into the fatty skin layer for 2-3 days to check tolerance.
Continuation : Increase to maximum of 40 (0.4) gradually on the syringe and inject it into the tummy under the skin into the fatty skin layer.
How long will a vial last ?
A vial should last 5-7 days.
Whatsapp our support team now for help with this item or others ! Click HERE to connect with us !
Reviews
There are no reviews yet.